David Evans, PhDCo-Founder and CSO at Sirnaomics
Dr. Evans obtained his BSc and PhD from Imperial College, London. Over the last 3 decades he has been responsible for building and leading scientific research teams focused on target validation and drug discovery in Oncology and other indications. David has more than 15 years’ experience in the RNAi field – building genome scale screening capabilities for target identification at TGEN and Dharmacon prior to cofounding Sirnaomics to focus on developing siRNA as a therapeutic. David previously worked in the Boston area at Millennium Pharmaceuticals and Serono Pharmaceuticals.